Abstract

Incorporation of tritiated leucine into uterine protein was examined during the estrus cycle early pregnancy and pseudopregnancy. The effects of an antiimplantation compound ICI 46474 (trans-1-(rho-beta dimethylaminothoxyphenyl)-12 diphenyl but-1-ene) were also examined. No significant variation in the protein content of the uterine tissue occurred during the estrus cycle. There was a highly significant (p< .002) increase in the rate of incorporation of radioactive leucine into uterine protein during metestrus and diestrus. Incorporation of tritiated leucine into uterine protein showed a large increase on Days 3 and 4 of pseudopregnancy. .1 mg/kg ICI 46474 given on Day 2 reduced the size of the implantation sites measured on Day 9. A dose of .2 mg/kg inhibited implantation completely. In the group receiving .05 mg/kg ICI 46474 the radioactivity of the acid soluable pool decreased significantly (p< .05) as it also did in the control. The uptake of tritiated leucine was elevated in all groups on Day 3 followed by a decreased on Day 4. The decrease was greatest during treatment with .20 mg/kg.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.